Boston-based start-up Reverie Labs, a graduate of the Y Combinator accelerator, aims to speed up drug development by using machine learning and artificial intelligence (AI) to become a fully fledged "molecule-as-a-service" company. Reverie Labs’ founders Connor Duffy, Ankit Gupta and Jonah Kallenbach, who named their company after a pivotal detail in the HBO series The company is currently in beta testing with its first product, an app that allows users to order drugs from pharmacies or online pharmacies. The cloud-based system integrates into third-party workflows, and the company has already partnered with scientists and biotech firms working on treatments for flu and cancer.
Boston-based start-up Reverie Labs, a graduate of the Y Combinator accelerator, aims to speed up drug development by using machine learning and artificial intelligence (AI) to become a fully fledged "molecule-as-a-service" company. The company is currently in beta testing with its first product, an app that allows users to order drugs from pharmacies or online pharmacies. The cloud-based system integrates into third-party workflows, and the company has already partnered with scientists and biotech firms working on treatments for flu and cancer.